At the end of a tense year for science, the American Society of Hematology heard promising data on acute myeloid leukemia, ...

The Advisory Committee on Immunization Practice (ACIP)’s meetings used to be a geek’s dream: hours of long, maybe dreary ...

WASHINGTON — Federal vaccine advisers, through a freewheeling, and at times combative two-day meeting, recommended a major ...

Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.

Freenome, a Bay Area biotech that is part of the increasingly competitive race to accurately detect cancer early through ...

AI use has exploded in radiology as the field struggles with staffing shortages, exacerbated by growing imaging volumes.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

The CDC's ACIP panel voted to recommend delaying the birth dose of the hepatitis B vaccine, ending a policy that has reined ...

In today's Pharmalittle roundup, we're reading about FDA's Prasad defending his plans, a Merck setback in Germany, and more.

At a closed-door investor conference in New York, FDA vaccines chief Vinay Prasad railed against “misleading media narratives” as backlash mounts over his push to require larger, longer studies for ...

“We have the evidence and tools to eliminate cervical cancer. What remains is the collective will to implement them equitably ...

The complexity of developing and manufacturing, coupled with market and regulatory dynamics, has put biosimilars out of reach ...